{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:40:55Z","timestamp":1791337255824,"version":"4.3.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"the Intramural Research Program of the National Institutes of Health, National Cancer Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.drup.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,4,6]],"date-time":"2012-04-06T08:00:25Z","timestamp":1333699225000},"page":"98-105","source":"Crossref","is-referenced-by-count":296,"title":["Collateral sensitivity as a strategy against cancer multidrug resistance"],"prefix":"10.1016","volume":"15","author":[{"given":"Kristen M.","family":"Pluchino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Goldsborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Gottesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2012.03.002_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF01534700","article-title":"Isolation and genetic characterization of human KB cell lines resistant to multiple drugs","volume":"11","author":"Akiyama","year":"1985","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.drup.2012.03.002_bib0010","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1016\/S0021-9258(18)53597-3","article-title":"Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein","volume":"268","author":"al-Shawi","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0015","first-page":"3084","article-title":"P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential","volume":"63","author":"Aleman","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drup.2012.03.002_bib0025","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1016\/j.bmc.2010.07.031","article-title":"Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1","volume":"18","author":"Barattin","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.1040880104","article-title":"Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity","volume":"88","author":"Bech-Hansen","year":"1976","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.drup.2012.03.002_bib0035","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/bjc.1998.708","article-title":"2-Deoxy-d-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis","volume":"78","author":"Bell","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2012.03.002_bib0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0304-3835(97)04739-3","article-title":"The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation","volume":"115","author":"Bentley","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2012.03.002_bib0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00432-004-0653-9","article-title":"Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications","volume":"131","author":"Berger","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.drup.2012.03.002_bib0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gde.2010.10.009","article-title":"Searching for synthetic lethality in cancer","volume":"21","author":"Brough","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.drup.2012.03.002_bib0055","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1096\/fasebj.2.7.3350243","article-title":"Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells","volume":"2","author":"Broxterman","year":"1988","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2012.03.002_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2012.03.002_bib0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/156720107782151241","article-title":"ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug\u2013drug interactions","volume":"4","author":"Calcagno","year":"2007","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.drup.2012.03.002_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0005-2736(95)00042-2","article-title":"Collateral sensitivity of multidrug resistant cells to narcotic analgesics is due to effects on the plasma membrane","volume":"1236","author":"Callaghan","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drup.2012.03.002_bib0075","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/0006-2952(87)90139-0","article-title":"Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation","volume":"36","author":"Cano-Gauci","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2012.03.002_bib0080","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tips.2006.06.008","article-title":"Transport of glutathione and glutathione conjugates by MRP1","volume":"27","author":"Cole","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drup.2012.03.002_bib0085","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drup.2012.03.002_bib0090","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor","volume":"7","author":"Fox","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.drup.2012.03.002_bib0095","doi-asserted-by":"crossref","first-page":"e11253","DOI":"10.1371\/journal.pone.0011253","article-title":"Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate","volume":"5","author":"Ganguly","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2012.03.002_bib0100","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/cmdc.201100102","article-title":"Identification of Xanthones as Selective Killers of Cancer Cells Overexpressing the ABC Transporter MRP1","volume":"6","author":"Genoux-Bastide","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drup.2012.03.002_bib0105","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1021\/jm2001663","article-title":"Collateral Sensitivity of Multidrug-Resistant Cells to the Orphan Drug Tiopronin","volume":"54","author":"Goldsborough","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0110","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nbt0609-546","article-title":"Structure of a multidrug transporter","volume":"27","author":"Gottesman","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2012.03.002_bib0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2012.03.002_bib0120","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1021\/jm2006047","article-title":"Synthesis and structure\u2013activity evaluation of isatin-beta-thiosemicarbazones with improved selective activity towards multidrug-resistant cells expressing P-glycoprotein","volume":"54","author":"Hall","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0125","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2009.07.003","article-title":"Is resistance useless? Multidrug resistance and collateral sensitivity","volume":"30","author":"Hall","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drup.2012.03.002_bib0130","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1021\/jm800861c","article-title":"Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells","volume":"52","author":"Hall","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0135","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.drup.2012.03.002_bib0140","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.1074\/jbc.M207781200","article-title":"Role of reduced glutathione efflux in apoptosis of immortalized human keratinocytes induced by UVA","volume":"278","author":"He","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/cdd.1984.1.353","article-title":"Calcium channel blocker enhancement of anticancer drug cytotoxicity--a review","volume":"1","author":"Helson","year":"1984","journal-title":"Cancer Drug Deliv."},{"key":"10.1016\/j.drup.2012.03.002_bib0150","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jinorgbio.2010.07.012","article-title":"The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: an EPR study","volume":"104","author":"Jansson","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.drup.2012.03.002_bib0155","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s004670050736","article-title":"Treatment of cystinuria","volume":"13","author":"Joly","year":"1999","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.drup.2012.03.002_bib0160","first-page":"1638","article-title":"The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity","volume":"51","author":"Kaplan","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0165","first-page":"544","article-title":"Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism","volume":"50","author":"Kaplan","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0170","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/BF01948335","article-title":"Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation","volume":"37","author":"Kappus","year":"1981","journal-title":"Experientia"},{"key":"10.1016\/j.drup.2012.03.002_bib0175","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1021\/bi034149+","article-title":"A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity","volume":"42","author":"Karwatsky","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2012.03.002_bib0180","first-page":"433","article-title":"Two-deoxyglucose as an anti-metabolite in human carcinoma cell line RPMI-2650 and drug-resistant variants","volume":"24","author":"Keenan","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1158\/1078-0432.CCR-10-1725","article-title":"A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer","volume":"17","author":"Kelly","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2012.03.002_bib0195","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bcp.2011.02.013","article-title":"A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways","volume":"81","author":"Kuo","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2012.03.002_bib0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.abb.2009.09.012","article-title":"P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil","volume":"491","author":"Laberge","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.drup.2012.03.002_bib0205","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2004-05-1866","article-title":"Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation","volume":"104","author":"Le","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.drup.2012.03.002_bib0210","first-page":"31","article-title":"The role of iron in cell cycle progression and the proliferation of neoplastic cells","volume":"1603","author":"Le","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drup.2012.03.002_bib0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.drup.2012.03.002_bib0220","first-page":"530","article-title":"Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1)","volume":"293","author":"Loe","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drup.2012.03.002_bib0225","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1158\/0008-5472.CAN-05-3322","article-title":"Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer","volume":"66","author":"Ludwig","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0230","first-page":"870","article-title":"Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy","volume":"48","author":"Lyon","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0235","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/np100429s","article-title":"The selectivity of austocystin D arises from cell-line-specific drug activation by cytochrome P450 enzymes","volume":"74","author":"Marks","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.drup.2012.03.002_bib0240","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ijc.2910560523","article-title":"Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines","volume":"56","author":"Muller","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2012.03.002_bib0245","first-page":"1452","article-title":"Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement","volume":"49","author":"Naito","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0250","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1021\/jm701208v","article-title":"Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity","volume":"51","author":"Nakagawa-Goto","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0255","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1021\/jm100846r","article-title":"Antitumor agents 280. Multidrug resistance-selective desmosdumotin B analogues","volume":"53","author":"Nakagawa-Goto","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0260","article-title":"Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression","author":"Nobili","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.drup.2012.03.002_bib0265","doi-asserted-by":"crossref","first-page":"31542","DOI":"10.1074\/jbc.M703964200","article-title":"(R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1","volume":"282","author":"Perrotton","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2012.03.002_bib0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00132580-200101000-00008","article-title":"Verapamil revisited: a transition in novel drug delivery systems and outcomes","volume":"3","author":"Prisant","year":"2001","journal-title":"Heart Dis."},{"key":"10.1016\/j.drup.2012.03.002_bib0275","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/138920111795163913","article-title":"The challenge of exploiting ABCG2 in the clinic","volume":"12","author":"Robey","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.drup.2012.03.002_bib0280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABCG2: determining its relevance in clinical drug resistance","volume":"26","author":"Robey","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.drup.2012.03.002_bib0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2004.06.026","article-title":"Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells","volume":"6","author":"Szakacs","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2012.03.002_bib0285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2012.03.002_bib0290","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/JB.64.4.489-499.1952","article-title":"Genetic studies on microbial cross resistance to toxic agents: I. Cross resistance of Escherichia coli to fifteen antibiotics","volume":"64","author":"Szybalski","year":"1952","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.drup.2012.03.002_bib0295","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/01635581.2011.535959","article-title":"Modulation of P-glycoprotein-mediated anticancer drug accumulation, cytotoxicity, and ATPase activity by flavonoid interactions","volume":"63","author":"Tran","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.drup.2012.03.002_bib0300","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1158\/0008-5472.CAN-04-0143","article-title":"Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1","volume":"64","author":"Trompier","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0305","first-page":"2905","article-title":"Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers","volume":"43","author":"Tsuruo","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0310","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0315","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1158\/0008-5472.CAN-09-2422","article-title":"Identification of compounds selectively killing multidrug-resistant cancer cells","volume":"69","author":"Turk","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0320","first-page":"4477","article-title":"Properties of verapamil-hypersensitive multidrug-resistant Chinese hamster ovary cells","volume":"48","author":"Warr","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0325","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0309-1651(86)90011-1","article-title":"Verapamil hypersensitivity of vincristine resistant Chinese hamster ovary cell lines","volume":"10","author":"Warr","year":"1986","journal-title":"Cell Biol. Int. Rep."},{"key":"10.1016\/j.drup.2012.03.002_bib0330","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drup.2012.03.002_bib0335","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1158\/1535-7163.MCT-07-2005","article-title":"Evidence for dual mode of action of a thiosemicarbazone. NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter","volume":"6","author":"Wu","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2012.03.002_bib0340","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1158\/0008-5472.613.65.2","article-title":"Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia","volume":"65","author":"Xu","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2012.03.002_bib0345","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.drup.2012.03.002_bib0350","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","article-title":"Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition","volume":"38","author":"Zhou","year":"2008","journal-title":"Xenobiotica"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764612000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764612000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T16:19:58Z","timestamp":1687364398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764612000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":71,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1368764612000143"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2012.03.002","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}